autoimmune epilepsy some epilepsy patients harbor autoantibodies to glutamate receptors and dsdna on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy英文论文.pdfVIP

下载本文档

4
0
约8.55万字
约 13页
2017-08-27 发布于上海
举报
版权申诉

autoimmune epilepsy some epilepsy patients harbor autoantibodies to glutamate receptors and dsdna on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy英文论文.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

autoimmune epilepsy some epilepsy patients harbor autoantibodies to glutamate receptors and dsdna on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy英文论文

Clinical Developmental Immunology, September/December 2004, Vol. 11 (3/4), pp. 241–252 Autoimmune Epilepsy: Some Epilepsy Patients Harbor Autoantibodies to Glutamate Receptors and dsDNA on both Sides of the Blood–brain Barrier, which may Kill Neurons and Decrease in Brain Fluids after Hemispherotomy a b,c d e,c YONATAN GANOR , HADASSA GOLDBERG-STERN , DINA AMROM , TALLY LERMAN-SAGIE , VIVIAN a f f g,c h I. TEICHBERG , DORI PELLED , ANTHONY H. FUTERMAN , BRURIA BEN ZEEV , MICHAEL FREILINGER , DENIS VERHEULPENi i a,c, , PATRICK VAN BOGAERT and MIA LEVITE * aDepartment of Neurobiology, The Weizmann Institute of Science, Rehovot, Israel; bEpilepsy Center, Schneider Children’s Medical Center of Israel, c d ˆ Petah Tiqwa, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Child Neurology, Hopital Franc¸ais-ULB, e f Brussels, Belgium; Pediatric Neurology Unit, Wolfson Medical Center, Holon, Israel; Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel; gDepartment of Child Neurology and Epilepsy, Sheba Medical Center, Tel Hashomer, Israel; hDepartment of Pediatrics, University Hospital of Vienna,